Quarterly report pursuant to Section 13 or 15(d)

Note 15 - Stock-based Compensation and Other Benefit Plans - SAR Activity (Details)

v3.23.2
Note 15 - Stock-based Compensation and Other Benefit Plans - SAR Activity (Details) - Stock Appreciation Rights (SARs) [Member]
$ / shares in Units, shares in Thousands, $ in Thousands
 6 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Outstanding, number of underlying shares (in shares) | shares 202
Outstanding, weighted average exercise price per share (in dollars per share) | $ / shares $ 1.87
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | shares 0
Granted, weighted average exercise price per share (in dollars per share) | $ / shares $ 0
Exercised, number of underlying shares (in shares) | shares (63)
Exercised, weighted average exercise price per share (in dollars per share) | $ / shares $ 0.86
Unvested SARs forfeited, number of underlying shares (in shares) | shares 0
Unvested SARs forfeited, weighted average exercise price per share (in dollars per share) | $ / shares $ 0
Vested SARs expired, number of underlying shares (in shares) | shares 0
Vested SARs expired, weighted average exercise price per share (in dollars per share) | $ / shares $ 0
Outstanding, number of underlying shares (in shares) | shares 139
Outstanding, weighted average exercise price per share (in dollars per share) | $ / shares $ 2.33
Outstanding, weighted average remaining contractual term (Year) 7 months 20 days
Outstanding, aggregate intrinsic value | $ $ 198
Exercisable, number of underlying shares (in shares) | shares 139
Exercisable, weighted average exercise price per share (in dollars per share) | $ / shares $ 2.33
Exercisable, weighted average remaining contractual term (Year) 7 months 20 days
Exercisable, aggregate intrinsic value | $ $ 198